Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0B7CH
|
|||
| Former ID |
DCL000929
|
|||
| Drug Name |
Phenylbutyrate
|
|||
| Synonyms |
Benzenebutyric acid; Phenyl butanoate; Phenyl butyrate; HDInhib_000004; Butanoic acid, phenyl ester; Butyric acid, phenyl ester; FR-2080; Gamma-Phenylbutyric acid; Omega-Phenylbutanoic acid; GAMMA-PHENYL-BUTYRIC ACID; Butyric acid, 4-phenyl-(8CI); 1-Phenylbutyric acid; 4-PHENYL-BUTANOIC ACID; 4-PHENYLBUTYRIC ACID; 4-Phenylbutanoic acid; 4-phenylbutans; 4-phenylbutyrate
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Urea cycle disorder [ICD-11: 5C50.A; ICD-10: E72.2; ICD-9: 270.6] | Phase 2 | [1], [2] | |
| Company |
Scandinavian
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C10H12O2
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)CCCC(=O)O
|
|||
| InChI |
1S/C10H12O2/c11-10(12)8-4-7-9-5-2-1-3-6-9/h1-3,5-6H,4,7-8H2,(H,11,12)
|
|||
| InChIKey |
OBKXEAXTFZPCHS-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 1821-12-1
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
67217, 855904, 3134204, 5292415, 7886648, 8152932, 10511345, 11342085, 11362268, 11364225, 11366787, 11369349, 11371804, 11373523, 11377511, 11406848, 11424503, 11485491, 11487670, 11489614, 11490598, 11491907, 11495145, 15321781, 24898272, 26679333, 29199328, 29223859, 46393851, 46506332, 47216579, 47440033, 48334266, 48438876, 49831441, 50064557, 50100827, 50835531, 56311000, 56311078, 56422199, 57288416, 57288448, 57322443, 85173139, 85789498, 85789605, 87574802, 87691612, 88519576
|
|||
| ChEBI ID |
CHEBI:41500
|
|||
| SuperDrug ATC ID |
R05DB09
|
|||
| SuperDrug CAS ID |
cas=000468611
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8480). | |||
| REF 2 | Emerging disease-modifying therapies for the treatment of motor neuron disease/amyotropic lateral sclerosis. Expert Opin Emerg Drugs. 2007 May;12(2):229-52. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.